Fortitude Biomedicines is pioneering the next generation of antibody-based biotherapeutics to transform the treatment of autoimmune diseases and cancer, utilizing their proprietary GLUE-DAC™ platform for innovative biologics and antibody-drug conjugates
Fortitude Biomedicines is pioneering the next generation of antibody-based biotherapeutics to transform the treatment of autoimmune diseases and cancer, utilizing their proprietary GLUE-DAC™ platform for innovative biologics and antibody-drug conjugates.